IGF2BP3 and neoplasm: As a result, in CRC, METTL3, METTL14, WTAP, IGF2BP3, YTHDC1, and FTO orchestrate tumor angiogenesis through diverse pathways and mechanisms, thereby affecting the initiation, progression, and prognosis of CRC.